LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.5350
-0.0150 (-2.73%)
At close: Jan 29, 2026

LTR Pharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
9752109---
Market Cap Growth
-27.89%-51.74%----
Enterprise Value
6518103---
Last Close Price
0.540.290.78---
PS Ratio
64.4634.792219.25---
PB Ratio
3.091.6736.98---
P/TBV Ratio
3.091.6736.98---
EV/Sales Ratio
43.3712.212096.41---
Debt / Equity Ratio
------8.81
Asset Turnover
0.090.090.02-0.01-
Quick Ratio
45.7645.767.8684.374.110.32
Current Ratio
45.7845.787.8684.374.110.32
Return on Equity (ROE)
-32.47%-32.47%-277.45%-75.74%-118.83%-
Return on Assets (ROA)
-21.45%-21.45%-158.79%-41.36%-47.61%-
Return on Capital Employed (ROCE)
-19.40%-19.40%-236.00%-69.30%-57.40%70.00%
Earnings Yield
-5.75%-10.66%-6.40%---
FCF Yield
-4.58%-8.48%-4.69%---
Buyback Yield / Dilution
-19.96%-19.96%46.34%---
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.